rosiglitazone has been researched along with Polyuria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade, L; da Silva, CA; de Bragança, AC; Fortes, MA; Giorgi, RR; Sanches, TR; Seguro, AC; Shimizu, MH | 1 |
1 other study(ies) available for rosiglitazone and Polyuria
Article | Year |
---|---|
Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression.
Topics: Animals; Aquaporin 2; Drug Interactions; Hypoglycemic Agents; Hypokalemia; Immunosuppressive Agents; Kidney; Kidney Function Tests; Magnesium; Male; Polyuria; Rats; Rats, Wistar; Rosiglitazone; Sirolimus; Sodium; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Thiazolidinediones; TRPM Cation Channels; Water | 2009 |